LJP 394

· La Jolla Pharmaceutical Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LJP 394, covering 2009-04-01 to 2009-04-01. Get the full timeline:

Most recent: Clinical Trial Update: Study of LJP 394 in Lupus Patients With History of Renal Disease [Phase 3]